CD8A and experimental autoimmune encephalomyelitis: Transfer of CD8+CD122+ Tregs significantly improved clinical symptoms of experimental autoimmune encephalomyelitis (EAE) (37), whereas IL-15-dependent CD8+CD122+ Tregs also ameliorated EAE by suppressing IL-17 production (38).